Pay in 4 interest-free payments of $6.26 Learn more
Ships within 48 hours · Estimated delivery Nov 2 - Nov 7
Human clinical-trial data (Phase 1/2 studies in wound healing, cardiac injury, and dry eye) exist only for a different, full-length recombinant thymosin beta-4 product, not for the short synthetic fragment marketed as TB-500, so no completed published human trial has evaluated TB-500 specifically for muscle, tendon, or joint recovery
It was hypothesised that the organophosphates induce various abnormalities such as an elevated prevalence of lymphoproliferative disorders associated with impaired natural killer (NK) cell and cytotoxic T cell function
Description: Supports nerve comfort and a healthy inflammatory response
With its unrivaled healing properties, BPC 157 has emerged as a game-changer in supporting the body's natural healing processes
Suitable for studies involving GHRH-receptor pathway characterization and method development in model systems
The tb-500 peptide side effects documented in available research are generally mild and well tolerated
